Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2005 2
2006 1
2007 1
2008 3
2009 2
2010 3
2011 4
2012 4
2013 5
2014 6
2015 1
2016 3
2017 1
2019 2
2020 10
2021 5
2022 8
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer.
Bakht MK, Yamada Y, Ku SY, Venkadakrishnan VB, Korsen JA, Kalidindi TM, Mizuno K, Ahn SH, Seo JH, Garcia MM, Khani F, Elemento O, Long HW, Chaglassian A, Pillarsetty N, Lewis JS, Freedman M, Belanger AP, Nguyen QD, Beltran H. Bakht MK, et al. Among authors: pillarsetty n. Nat Cancer. 2023 May;4(5):699-715. doi: 10.1038/s43018-023-00539-6. Epub 2023 Apr 10. Nat Cancer. 2023. PMID: 37038004 Free PMC article.
Radioimmunotherapy Targeting Delta-like Ligand 3 in Small Cell Lung Cancer Exhibits Antitumor Efficacy with Low Toxicity.
Tully KM, Tendler S, Carter LM, Sharma SK, Samuels ZV, Mandleywala K, Korsen JA, Delos Reyes AM, Piersigilli A, Travis WD, Sen T, Pillarsetty N, Poirier JT, Rudin CM, Lewis JS. Tully KM, et al. Among authors: pillarsetty n. Clin Cancer Res. 2022 Apr 1;28(7):1391-1401. doi: 10.1158/1078-0432.CCR-21-1533. Clin Cancer Res. 2022. PMID: 35046060 Free PMC article.
Delta-like ligand 3-targeted radioimmunotherapy for neuroendocrine prostate cancer.
Korsen JA, Gutierrez JA, Tully KM, Carter LM, Samuels ZV, Khitrov S, Poirier JT, Rudin CM, Chen Y, Morris MJ, Bodei L, Pillarsetty N, Lewis JS. Korsen JA, et al. Among authors: pillarsetty n. Proc Natl Acad Sci U S A. 2022 Jul 5;119(27):e2203820119. doi: 10.1073/pnas.2203820119. Epub 2022 Jun 27. Proc Natl Acad Sci U S A. 2022. PMID: 35759660 Free PMC article.
Oncology-Inspired Treatment Options for COVID-19.
Pillarsetty N, Carter LM, Lewis JS, Reiner T. Pillarsetty N, et al. J Nucl Med. 2020 Dec;61(12):1720-1723. doi: 10.2967/jnumed.120.249748. Epub 2020 Jul 17. J Nucl Med. 2020. PMID: 32680924 Free PMC article.
A one-pot radiosynthesis of [18 F]PARPi.
Wilson TC, Pillarsetty N, Reiner T. Wilson TC, et al. Among authors: pillarsetty n. J Labelled Comp Radiopharm. 2020 Jul;63(9):419-425. doi: 10.1002/jlcr.3847. Epub 2020 Jun 16. J Labelled Comp Radiopharm. 2020. PMID: 32391930 Free PMC article.
Noninvasive Imaging of CD4+ T Cells in Humanized Mice.
Nagle VL, Hertz CAJ, Henry KE, Graham MS, Campos C, Pillarsetty N, Schietinger A, Mellinghoff IK, Lewis JS. Nagle VL, et al. Among authors: pillarsetty n. Mol Cancer Ther. 2022 Apr 1;21(4):658-666. doi: 10.1158/1535-7163.MCT-21-0888. Mol Cancer Ther. 2022. PMID: 35131877 Free PMC article.
Improved radiosynthesis of 123I-MAPi, an auger theranostic agent.
Wilson TC, Jannetti SA, Guru N, Pillarsetty N, Reiner T, Pirovano G. Wilson TC, et al. Among authors: pillarsetty n. Int J Radiat Biol. 2023;99(1):70-76. doi: 10.1080/09553002.2020.1781283. Epub 2020 Jul 2. Int J Radiat Biol. 2023. PMID: 32552309 Free PMC article.
66 results